BNY Mellon UK Equity

Large cap UK equity fund with a bias to medium sized companies that targets growth as well as income.

  • 883.09p Price (Inc)
  • - Price (Acc)
  • 0.00% Initial charge
  • 1.50% Annual management charge
  • 1.61% Ongoing charges
  • 3.60% Yield

Prices as at 06 December 2019, fund data last updated 12 May 2014

The aim is to achieve capital growth and income from a portfolio of predominantly UK equities, investing principally in larger companies, though small and mid-sized stocks may also be included. The yield on this fund is enhanced by deducting charges from capital. Newton follow a global thematic approach, which sets the framework for which sectors to invest in. This Fund may also invest up to 20% in overseas stocks.

Fund summary

Sector UK All Companies
Structure OEIC
Launched May, 1985
Size £781m
Yield 3.60%
Charging basis Capital
Dividends paid 28 Feb, 31 May, 31 Aug, 30 Nov

Charges

Standard initial charge 0.00%
Initial charge via Bestinvest 0.00%
Additional bid/offer spread 0.00%
Annual management charge 1.50%
Ongoing charges figure 1.61%

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Investment process

The fund generally invests in companies with a market cap above £1bn due to stock liquidity and availability, though small and mid-cap stocks may be included. Stock selection generally reflects Newton’s in-house thematic views and the portfolio is chosen from the recommendations of Newton's global sector analysts. As a result the portfolio may include overseas stocks where these stand out compared to their UK counterparts. However, whilst the manager is guided by the house view, he is allowed enough freedom to stamp his authority on the fund. Typically the manager would prefer growth stocks, i.e. stocks growing their earnings at an above average rate as well as their dividends. However, the fund manager can be quite flexible and not follow either a value or growth investment style exclusively; instead concentrating on investing in attractively valued stocks with good prospects and strong fundamentals. Companies with sound balance sheets are generally sought as well as companies with a good ability to generate above average returns from their invested capital base. Every stock has a predefined price target which is constantly reviewed through the regional, global and research meetings.

In recent years the fund has suffered from Newton's global house themes, which generally have been out of favour with prevailing markets, as well as inconsistency of fund manager tenure. Its most recent fund manager Richard Wilmot took control of the fund in March 2011. The fund is not rated by Bestinvest at present and investors looking for another income-biased UK equity growth style fund could consider JO Hambro CM UK Opportunities rated 5 stars or Old Mutual UK Alpha rated 4 stars.

Manager research

Average monthly relative returns

  • 14/15 0.00%
  • 15/16 0.00%
  • 16/17 -0.50%
  • 17/18 -0.04%
  • 18/19 0.32%

Bestinvest MRI

  • 3 years -0.07%
  • 5 years 0.00%
  • Career 0.02%
  • 3 years 49.60%
  • 5 years 0.00%
  • Career 81.10%

Performance figures are based on the average of monthly percentage returns relative to the benchmark index.

Christopher Metcalfe

Metcalfe was born in 1960 and has a degree in Modern History as well as an MBA from Manchester Business School. His investment career commenced in 1985 at Henderson Adminstration Group, where he ultimately became Head of UK Equities. He joined Schroders in 1994, becoming a UK Equity fund manager for a number of their largest client portfolios, head of the Core UK Equity Team and an Executive Director. In 2006 he joined Newton as a Director in the UK Equity Team.

Track record

Christopher Metcalfe has 10.2 years experience of managing mutual funds in this sector. Over this period the average monthly return relative to the benchmark index has been +0.02%. During the worst period of relative performance (from February 2009 - January 2018) there was a decline of 28% relative to the index. The worst absolute loss has been 26%. Statistically, we estimate the probability that this fund manager is adding value, rather than being lucky, is 81%.

Periods of worst performance

Absolute -26.00% (December 2007 - March 2009)
Relative -28.00% (February 2009 - January 2018)

About the MRI

Our unique indicator: the Bestinvest Manager Record Index (MRI) measures the likelihood that the fund manager is adding value through their decisions. It is based on their performance record over the course of their career, adjusted for the amount of risk taken. MRI is an important contributor to our fund rating system but it is also vital to take account of qualitative factors. It is also very important to select funds to form a cohesive portfolio with an appropriate overall risk level.

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Allocation

Proportion (%)

  • {{chartDataItem.text}}
    {{chartDataItem.value}}

Top 10 holdings

Data accurate as at 31 August 2019

7.5402% Royal Dutch Shell
6.8809% Diageo
4.6405% Bp
4.4137% Unilever
4.1816% Astrazeneca Plc
3.9449% Relx Nv
3.2694% Prudential Plc
3.2584% Compass Group
2.92% British American Tobacco
2.878% Lloyds Banking Group Plc
Source: Trustnet

Sector breakdown

Financials 18.00%
Consumer Goods 18.00%
Industrials 17.00%
Health Care 13.00%
Oil & Gas 12.00%
Consumer Services 12.00%
Basic Materials 5.00%
Money Market 2.00%
Utilities 2.00%
Technology 1.00%

Portfolio

The fund holds around 30-60 stocks.

Constraints

Maximum 20% in overseas stocks. Long-term tracking error 2% to 6%. Maximum 5% in cash.

Key Investor Information

Download